49
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Do the Immunosuppressive Drugs used as Treatment for Graft-versus-host Disease Directly Inhibit Lymphoid Tumor Cell Growth?

, &
Pages 139-142 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jonathan M Durnian, Rosalind MK Stewart, Richard Tatham, Mark Batterbury & Stephen B Kaye. (2007) Cyclosporin-A associated malignancy. Clinical Ophthalmology 1:4, pages 421-430.
Read now

Articles from other publishers (3)

Huijie Jia, Tiesuo Zhao, Yinghua Ji, Xiaolong Jia, Wenjing Ren, Chen Li, Minming Li, Yali Xiao, Hui Wang & Kailin Xu. (2016) Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Cell Death & Disease 7:12, pages e2507-e2507.
Crossref
Jian Chen, Shuai Chen, Jiahui Wang, Mingjun Zhang, Zhaohua Gong, Youheng Wei, Li Li, Yuanyuan Zhang, Xuemei Zhao, Songmin Jiang & Long Yu. (2015) Cyclophilin J Is a Novel Peptidyl-Prolyl Isomerase and Target for Repressing the Growth of Hepatocellular Carcinoma. PLOS ONE 10:5, pages e0127668.
Crossref
Peter J. Bugelski, Amy Volk, Mindi R. Walker, John H. Krayer, Pauline Martin & Jacques Descotes. (2010) Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia. International Journal of Toxicology 29:5, pages 435-466.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.